)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Innoviva
Innoviva (INVA) investor relations material
Innoviva Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary26 Feb, 2026
Business overview and recent performance
Three main business components: royalty revenues from respiratory assets, specialty therapeutics (IST), and a diversified portfolio of strategic healthcare assets.
Royalty portfolio generated $250 million in gross revenue last year; IST delivered nearly $120 million in U.S. sales, expected to reach at least $150 million this year.
Strategic healthcare assets valued at over $600 million, with all business segments showing strong momentum into 2026.
IST business achieved its best quarter ever with $34 million in U.S. sales, marking the third consecutive year of 50% annual growth.
Major advances in strategic assets, notably Armata, which saw breakthrough clinical results and significant valuation increases.
Capital allocation and growth strategy
Over $500 million in cash enables flexibility for investments, acquisitions, and shareholder returns.
IST business offers opportunities for both organic and inorganic growth, with active evaluation of additional hospital channel assets.
Ongoing support for strategic healthcare assets like Armata and Syndeio, with continued disciplined evaluation of new investments.
$125 million share buyback program announced, reflecting commitment to shareholder value.
Pipeline and product updates
ZEVTERA, acquired from Basilea, is progressing through hospital formulary reviews, with positive initial feedback and improved reimbursement status.
NUZOLVENCE (zoliflodacin) approved for urogenital gonorrhea, with commercialization planned for the second half of the year; strategy focuses on targeted promotion and scaling as resistance to current treatments grows.
IST platform expected to exceed $150 million in U.S. net product sales in 2026, with GIAPREZA and XACDURO as key growth drivers.
GIAPREZA delivered $72 million in 2025 sales, with potential to surpass $100 million; XACDURO reached $33 million, with analyst expectations of $150–$200 million.
XERAVA provides stable revenue, while ZEVTERA and NUZOLVENCE have significant future market potential.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Innoviva earnings date
Q1 20266 May, 2026
Innoviva
Next Innoviva earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Innoviva Inc. is a biopharmaceutical company focused on managing and developing royalty portfolios. The company's primary business involves the commercialization of its portfolio of royalties, primarily derived from partnerships with pharmaceutical companies. Innoviva's portfolio includes interests in respiratory medicines and other therapeutic areas, where it receives royalties from the sale of these products. The company is involved in actively managing its royalty portfolio and exploring potential acquisitions or partnerships to expand its interests in healthcare assets. The company is headquartered in Burlingame, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage